Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

News

The RECOVERY Trial was overall winner of the Project Management Institute’s 2020 Awards UK's Best COVID-19 Response Project 2020 Category.

RECOVERY Trial announced as overall winner of Best COVID-19 Response Project Award in the UK

RECOVERY Trial named joint winner of HDR UK’s Impact of the Year Award

RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response

Martin Landray and Peter Horby

RECOVERY Chief Investigators recognised in Queen’s Birthday Honours

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

Society for Clinical Trials logo thumbnail

RECOVERY trial named David Sackett Trial of the Year 2020

RECOVERY research teams win awards for outstanding contribution to COVID-19 research

Martin Landray and Peter Horby

RECOVERY chief investigators elected to prestigious Academy of Medical Sciences Fellowship

Public webinar 'The RECOVERY Trial: one year on'

Event date and time: Wednesday 7 April 2021, 09.00 - 10.00 BST.

RECOVERY trial closes recruitment to colchicine treatment for patients hospitalised with COVID-19

Statement from the RECOVERY trial chief investigators, 5 March 2021

World’s largest clinical trial for COVID-19 treatments expands internationally

Tocilizumab reduces deaths in patients hospitalised with COVID-19

Baricitinib to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Statement from the RECOVERY trial chief investigators, 15 January 2021

John Curtis. Image courtesy of NHS Blood and Transplant.

Update on recruitment to convalescent plasma and tocilizumab treatment arms

Statement from the RECOVERY trial chief investigators, 11 January 2021

Leicester’s hospitals recruit over 1,000 patients for the RECOVERY trial

RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020

RECOVERY trial shortlisted for the National Project Awards 2020 Special COVID-19 response category

The RECOVERY trial has been selected as one of ten finalists in the Special COVID-19 response category in the 2020 National Project Awards, organised by PMI UK, in association with PricewaterhouseCoopers (PwC).

Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

RECOVERY trial clinicians can now be accredited through the Associate Principal Investigator Scheme

Load More